Literature DB >> 8620402

A 10-year experience with Japanese-type radical lymph node dissection for gastric cancer outside of Japan.

G R Jatzko1, P H Lisborg, H Denk, M Klimpfinger, H M Stettner.   

Abstract

BACKGROUND: The prognosis for surgically treated gastric cancer remains poor in most Western countries compared with reports from Japanese investigators during the past 3 decades.
METHODS: A radical surgical procedure principally to extended lymphadenectomy as defined by the Japanese Research Society for Gastric Cancer was performed prospectively from January 1984 to June 30, 1994 for 512 patients with gastric cancer, 345 of whom were treated with potentially curative surgery. Clinical, histopathologic, and surgical factors were examined for their influence on long term survival by univariate and multivariate analyses.
RESULTS: Five- and 10-year survival rates for all patients were 40.5% and 34.3%, respectively, and for patients who underwent tumor resection were 45.7% and 38.6%, respectively. For patients who underwent curative surgery, 5- and 10-year adjusted survival rates were 57.7% and 44.3%, respectively, with a median survival of 96 months. Postoperative hospital mortality was 6.8%:4.9% for R-0 resected patients, 9% for R-1 and R-2 resected patients, and 13.4% for those with palliative procedures. Multivariate analysis using the Cox model identified age older than 65 years, prior total gastrectomy, an increasing number of positive lymph nodes, a high pathologic N classification, male sex, a high pT classification, and low preoperative hemoglobin level as detrimental factors with an independent influence on survival.
CONCLUSION: Radical lymphadenectomy in this 10-year Austrian study yielded survival rates similar to those in Japanese investigations without sacrificing low postoperative mortality. In particular, the relatively high overall survival rates seemed to reaffirm the value of radical lymph node dissection with wide resection margins.

Entities:  

Mesh:

Year:  1995        PMID: 8620402     DOI: 10.1002/1097-0142(19951015)76:8<1302::aid-cncr2820760803>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  19 in total

1.  Lymph node staging in gastric cancer: is location more important than Number? An analysis of 1,038 patients.

Authors:  M S Karpeh; L Leon; D Klimstra; M F Brennan
Journal:  Ann Surg       Date:  2000-09       Impact factor: 12.969

2.  D2 plus radical resection combined with perioperative chemotherapy for advanced gastric cancer with pyloric obstruction.

Authors:  Yian Du; Xiangdong Cheng; Zhiyuan Xu; Litao Yang; Ling Huang; Bing Wang; Pengfei Yu; Ruizeng Dong
Journal:  Chin J Cancer Res       Date:  2013-08       Impact factor: 5.087

3.  Subtotal or total gastrectomy for gastric cancer: impact of the surgical procedure on morbidity and prognosis--analysis of a 10-year experience.

Authors:  Ines Gockel; Sebastian Pietzka; Ursula Gönner; Gerhard Hommel; Theodor Junginger
Journal:  Langenbecks Arch Surg       Date:  2005-02-12       Impact factor: 3.445

4.  A new prognostic strategy for gastric carcinoma: mRNA expression of tumor growth-related factors in endoscopic biopsy specimens.

Authors:  M Nakamura; M Katano; K Fujimoto; T Morisaki
Journal:  Ann Surg       Date:  1997-07       Impact factor: 12.969

5.  Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.

Authors:  Bin Liang; Shan Wang; Xue-Guang Zhu; Yong-Xiang Yu; Zhi-Rong Cui; You-Zhi Yu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

6.  Survival trends in gastric cancer patients of Northeast China.

Authors:  Hao Zhang; Ling-Ling Sun; Yan-Li Meng; Guang-Yu Song; Jing-Jing Hu; Ping Lu; Bin Ji
Journal:  World J Gastroenterol       Date:  2011-07-21       Impact factor: 5.742

7.  Intraarterial chemotherapy as an adjuvant treatment in locally advanced gastric cancer.

Authors:  Antonios-Apostolos K Tentes; Sotirios K Markakidis; Charisios Karanikiotis; Aliki Fiska; Ioannis K Tentes; Vangelis G Manolopoulos; Thespis Dimitriou
Journal:  Langenbecks Arch Surg       Date:  2006-03-14       Impact factor: 3.445

8.  Survival after surgical treatment of early gastric cancer, surgical techniques, and long-term survival.

Authors:  Norihiro Yuasa; Yuji Nimura
Journal:  Langenbecks Arch Surg       Date:  2004-04-30       Impact factor: 3.445

9.  MDCT features in the differentiation of T4a gastric cancer from less-advanced gastric cancer: significance of the hyperattenuating serosa sign.

Authors:  T U Kim; S Kim; J W Lee; N K Lee; T Y Jeon; D Y Park
Journal:  Br J Radiol       Date:  2013-07-19       Impact factor: 3.039

10.  Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution.

Authors:  Woo Jin Hyung; Sung Soo Kim; Won Hyuk Choi; Jae Ho Cheong; Seung Ho Choi; Choong Bai Kim; Sung Hoon Noh
Journal:  Yonsei Med J       Date:  2008-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.